GRIFOLS | GRF - Ebit

Aktienkurs
9.09
Täglich Wechseln
-0.08 -0.92%
Monatlich
-5.74%
Jährlich
-0.74%
Q2 Prognose
8.71




Ebit Veränderung Datum
Alcon AG USD 297M 20M 2026-03
Almirall EUR 30.23M 12.8M 2025-12
Amadeus IT EUR 491.1M 152.2M 2026-03
Amarin USD -2.26M 564K 2025-12
argenx SE USD 394M 22.86M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Cie Automotive EUR 264.84M 21.12M 2025-12
Demant DKK 2.07B 201M 2025-12
Ence Energia y Celulosa EUR -37.27M 22.77M 2025-12
Essilor EUR 1.38B 626M 2025-12
Ferrovial EUR 542M 111M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 268M 395M 2026-03
Genmab DKK 260M 199M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 249M 103.11M 2026-03
Hikma Pharmaceutical USD 348M 31M 2025-12
Inditex EUR 2.05B 317M 2025-12
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Merck EUR 474M 738M 2025-12
Novartis USD 4.18B 118M 2026-03
Philips EUR 302M 417M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Smith & Nephew USD 440M 50M 2025-12
UCB EUR 1.29B 571M 2025-12
Viscofan EUR 42.17M 8.14M 2026-03